Subscribe to RSS
DOI: 10.1055/a-2810-4737
Venous Thromboembolism Risk Associated with MIDLINE Catheters and Peripherally Inserted Central Catheters, a Systematic Review and Meta-Analysis
Authors

Abstract
Background
Peripherally inserted central catheters (PICCs) and midline catheters (MCs) are widely used for medium- to long-term vascular access in hospitalized adults. While PICCs are associated with a known risk of venous thromboembolism (VTE), the thrombotic safety profile of MCs remains uncertain, with conflicting evidence and inconsistent definitions complicating risk assessments.
Objective
To compare the incidence of VTE, including deep vein thrombosis (DVT), superficial venous thrombosis (SVT), and pulmonary embolism (PE), between PICCs and MCs through a systematic review and meta-analysis of observational and randomized studies.
Methods
A systematic literature search across five databases. Data extraction and bias assessment were performed independently by two reviewers. The primary outcome was the incidence of VTE, defined in studies by DVT, SVT, PE, and catheter-related thrombosis (CRT) by catheter type. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using random- and common-effects models. Subgroup and sensitivity analyses explored heterogeneity by catheter type, insertion technique, placement setting, and publication period.
Results
A total of 29,680 catheters were included across 19 studies, comprising 14,200 MCs and 15,480 PICCs. The pooled analysis showed no statistically significant difference in overall VTE rates between MCs (3.5%) and PICCs (3.8%), with a pooled OR of 0.92 (95% CI: 0.70–1.22). Similarly, CRT rates did not differ significantly between the two device types (OR = 1.14, 95% CI: 0.74–1.76). In the subgroup of studies enrolling ≥ 25% of patients from intensive care units (ICUs), no significant difference in thrombotic risk was observed between MCs and PICCs (OR = 0.88, 95% CI: 0.72–1.07). No significant differences in VTE risk were observed when stratified by placement technique, clinical setting, or publication period. Across studies, reporting of critical patient-level risk factors and catheter characteristics was frequently incomplete or inconsistent.
Conclusion
Our analysis suggests MCs have no significant differences in the thrombotic profile compared to PICCs. Therefore, VTE risk alone should not determine catheter choice. Future prospective studies with standardized definitions and improved reporting are essential to guide optimal vascular access decisions in high-risk populations.
Keywords
midline catheters - peripherally inserted central catheters - venous thromboembolism - deep vein thrombosis - catheter-related thrombosis - pulmonary embolism - vascular access devices - PICC‡ These authors contributed equally to this article.
Publication History
Received: 09 November 2025
Accepted after revision: 10 February 2026
Accepted Manuscript online:
12 February 2026
Article published online:
24 February 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 van Rens MR, van der Lee R, Spencer TR. et al. WoCoVA Foundation (World Conference on Vascular Access) and of the Global Vascular Access Network (GloVANet). The NAVIGATE project: A GloVANet-WoCoVA position statement on the nomenclature for vascular access devices. J Vasc Access 2024 ;11297298241291248
- 2 Chopra V, Anand S, Hickner A. et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 2013; 382 (9889) 311-325
- 3 Pinelli F, Pittiruti M, Annetta MG. et al. A GAVeCeLT consensus on the indication, insertion, and management of central venous access devices in the critically ill. J Vasc Access 2024; 26 (04) 1096-1114
- 4 Balsorano P, Virgili G, Villa G. et al. Peripherally inserted central catheter-related thrombosis rate in modern vascular access era-when insertion technique matters: a systematic review and meta-analysis. J Vasc Access 2020; 21 (01) 45-54
- 5 Bahl A, Karabon P, Chu D. Midline catheter use and outcomes in hospitalized patients: Implications for vascular access selection. J Hosp Med 2019; 14 (03) 162-169
- 6 Lu H, Yang Q, Yang L. et al. The risk of venous thromboembolism associated with midline catheters compared with peripherally inserted central catheters: a systematic review and meta-analysis. Nurs Open 2022; 9 (03) 1873-1882
- 7 Urtecho M, Torres Roldan VD, Nayfeh T. et al. Comparing complication rates of midline catheter vs peripherally inserted central catheter: a systematic review and meta-analysis. Open Forum Infect Dis 2023; 10 (02) ofad024
- 8 Chopra V, Flanders SA, Saint S. et al. Infection risk associated with midline catheters: a systematic review. Ann Intern Med 2014; 161 (05) 319-328
- 9 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372 (71) n71
- 10 Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; 5 (01) 210
- 11 Sterne JAC, Savović J, Page MJ. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898
- 12 Higgins JPT, Morgan RL, Rooney AA. et al. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int 2024;
- 13 Deeks JJ, Higgins JPT, Altman DG. et al. Chapter 10: Analysing data and undertaking meta-analyses [last updated November 2024]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. eds. Cochrane Handbook for Systematic Reviews of Interventions, version 6.5. Cochrane; 2024
- 14 Schwarzer G. Meta: an R package for meta-analysis. R News 2007; 7 (03) 40-45 Bibliography Discussion
- 15 Bing S, Smotherman C, Rodriguez RG, Skarupa DJ, Ra JH, Crandall ML. PICC versus midlines: comparison of peripherally inserted central catheters and midline catheters with respect to incidence of thromboembolic and infectious complications. Am J Surg 2022; 223 (05) 983-987
- 16 Seo H, Altshuler D, Dubrovskaya Y. et al. The safety of midline catheters for intravenous therapy at a large academic medical center. Ann Pharmacother 2020; 54 (03) 232-238
- 17 Bahl A, Karabon P, Chu D. Comparison of venous thrombosis complications in midlines versus peripherally inserted central catheters: are midlines the safer option?. Clin Appl Thromb Hemost 2019; 25: 1076029619839150
- 18 Tso AR, Patniyot IR, Gelfand AA, Goadsby PJ. Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment. Neurology 2017; 89 (03) 279-283
- 19 Sharp R, Esterman A, McCutcheon H, Hearse N, Cummings M. The safety and efficacy of midlines compared to peripherally inserted central catheters for adult cystic fibrosis patients: a retrospective, observational study. Int J Nurs Stud 2014; 51 (05) 694-702
- 20 Giustivi D, Gidaro A, Baroni M, Paglia S. Tunneling technique of PICCs and Midline catheters. J Vasc Access 2022; 23 (04) 610-614
- 21 Xu T, Kingsley L, DiNucci S. et al. Safety and utilization of peripherally inserted central catheters versus midline catheters at a large academic medical center. Am J Infect Control 2016; 44 (12) 1458-1461
- 22 Swaminathan L, Flanders S, Horowitz J, Zhang Q, O'Malley M, Chopra V. Safety and outcomes of midline catheters vs peripherally inserted central catheters for patients with short-term indications: a multicenter study. JAMA Intern Med 2022; 182 (01) 50-58
- 23 Sebolt J, Buchinger J, Govindan S, Zhang Q, O'Malley M, Chopra V. Patterns of vascular access device use and thrombosis outcomes in patients with COVID-19: a pilot multi-site study of Michigan hospitals. J Thromb Thrombolysis 2022; 53 (02) 257-263
- 24 Gidaro A, Vailati D, Gemma M. et al. Retrospective survey from vascular access team Lombardy net in COVID-19 era. J Vasc Access 2022; 23 (04) 532-537
- 25 Gershengorn HB, Basu T, Horowitz JK. et al. The Association of Vasopressor Administration through a midline catheter with catheter-related complications. Ann Am Thorac Soc 2023; 20 (07) 1003-1011
- 26 Thomsen SL, Boa R, Vinter-Jensen L, Rasmussen BS. Safety and efficacy of midline vs peripherally inserted central catheters among adults receiving iv therapy: a randomized clinical trial. JAMA Netw Open 2024; 7 (02) e2355716
- 27 Lisova K, Paulinova V, Zemanova K, Hromadkova J. Experiences of the first PICC team in the Czech Republic. Br J Nurs 2015; 24 (02) S4 , S6, S10
- 28 Lescinskas EH, Trautner BW, Saint S. et al. Use of and patient-reported complications related to midline catheters and peripherally inserted central catheters. Infect Control Hosp Epidemiol 2020; 41 (05) 608-610
- 29 Caparas JV, Hu JP. Safe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical trial. J Vasc Access 2014; 15 (04) 251-256
- 30 Paje D, Walzl E, Heath M. et al. Midline vs peripherally inserted central catheter for outpatient parenteral antimicrobial therapy. JAMA Intern Med 2025; 185 (01) 83-91
- 31 Bentridi A, Giroux MF, Soulez G. et al. Midline venous catheter vs peripherally inserted central catheter for intravenous therapy: a randomized clinical trial. JAMA Netw Open 2025; 8 (03) e251258
- 32 Rosich-Soteras A, Bonilla-Serrano C, Llauradó-González MÀ. et al. Implementation of a vascular access team and an intravenous therapy programme: a first-year activity analysis. J Vasc Access 2025; 26 (02) 432-440
- 33 Tao F, Wang X, Liu J, Li J, Sui F. Perioperative application of midline catheter and PICC in Patients with gastrointestinal tumors. JBUON 2019; 24 (06) 2546-2552
- 34 Alexandrou E, Ramjan LM, Spencer T. et al. Worldwide prevalence of peripheral intravenous catheter use: a systematic review and meta-analysis. Lancet Glob Health 2018; 6 (10) e904-e913
- 35 Elli S, Pittiruti M, Pigozzo V. et al. Ultrasound-guided tip location of midline catheters. J Vasc Access 2020; 21 (05) 764-768
- 36 Huh PM, Fakhoury R, Hernandez M. et al. Dual-lumen midline catheters for vasopressor administration in the ICU: a retrospective study. Chest 2024; 165 (06) A1480
- 37 Karlsson H, Afrasiabi A, Ohlsson M, Månsson V, Hartman H, Torisson G. Treating shock with norepinephrine administered in midline catheters in an intermediary care unit: a retrospective cohort study. BMJ Open 2024; 14 (12) e091311
- 38 Prasanna P, Benjamin L, Raut A. et al. Safety of midline catheters for vasopressor administration in ICU: a retrospective cohort study. J Crit Care 2021; 62: 191-196
- 39 Parienti JJ, Mongardon N, Mégarbane B. et al; 3SITES Study Group. Intravascular complications of central venous catheterization by insertion site. N Engl J Med 2015; 373 (13) 1220-1229
- 40 Pittiruti M, La Greca A, Scoppettuolo G. The EKG method for positioning the tip of PICCs: results from a multicenter study. J Vasc Access 2012; 13 (03) 357-365
- 41 Maizel J, Guyomarc'h S, Henon P. et al. Echographic versus electrocardiogram guidance for the placement of PICCs in ICU: a randomized study. Intensive Care Med 2012; 38 (07) 1105-1111
- 42 Monreal M, Alastrue A, Roca J. et al. Upper-extremity deep venous thrombosis in cancer patients with venous access devices—prophylaxis and risk factors. Thromb Haemost 1996; 75 (04) 548-550
- 43 Evans RS, Sharp JH, Linford LH. et al. Risk of symptomatic DVT associated with PICCs. Chest 2010; 138 (04) 803-810
- 44 Bertoglio S, Faccini B, Lalli L. et al. Catheter-to-vein ratio predicts risk of PICC-related thrombosis: a prospective study. J Vasc Access 2017; 18 (05) 421-427
- 45 Vandergrift LA, Hockenberry MJ, Spurlock A. et al. Midline catheter complications in non-ICU patients: a prospective cohort. Am J Crit Care 2022; 31 (01) 12-20
- 46 Kowalski CM, Cunningham JN, Pinkerton J. et al. Thrombotic complications of midline catheters: a retrospective review. J Hosp Med 2020; 15 (06) 323-327
- 47 Dougherty L, Bravery K, Gabriel J. et al. Standards for infusion therapy: Thrombosis definitions and reporting. Br J Nurs 2016; 25 (Suppl. 14) S1-S81
- 48 Male C, Mitchell LG. Diagnostic challenges in catheter-associated thrombosis. Thromb Res 2018; 164 (Suppl. 01) S41-S45